SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048648
Filing Date
2024-04-26
Accepted
2024-04-26 07:05:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxy_notice_2023.htm DEFA14A 25708
2 GRAPHIC img23663029_0.jpg GRAPHIC 1716866
3 GRAPHIC img23663029_1.jpg GRAPHIC 451442
  Complete submission text file 0000950170-24-048648.txt   2871255
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41365 | Film No.: 24878543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)